MedTrace Logo

Observational Study Conducted on Patients Receiving the ESOP 2 Stem to Confirm Security and Performance of the Device

NCT04193163 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2026-02-02

No results posted yet for this study

Summary

This study is a post-market clinical follow-up conducted in order to collect long-term data on security and performance of the ESOP 2 stem, which is intended to be implanted in case of total hip replacement, when used in real life conditions according to the instructions for use.

Conditions

  • Hip Disease
  • Hip Fractures

Interventions

DEVICE

Hip prosthesis - ESOP 2 cementless femoral stem

ESOP 2 femoral stems are intended to be implanted in the femoral region during total hip arthroplasty in order to restore joint function.

Sponsors & Collaborators

  • FH ORTHO

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-01
Primary Completion
2022-09-01
Completion
2022-09-01
FDA Device
Yes

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04193163 on ClinicalTrials.gov